+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Anesthesia Drugs Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 5175788
  • Report
  • August 2020
  • Region: Europe
  • 75 pages
  • Mordor Intelligence

FEATURED COMPANIES

  • AbbVie Inc.
  • B. Braun Melsungen
  • Baxter International Inc.
  • F. Hoffmann-La Roche AG
  • Fresenius SE & Co. KGaA
  • Mylan NV
Certain factors that are driving the market growth include an increasing number of surgeries, new approvals of anesthetic drugs, and reduction in the cost of newly invented drugs.

The number of surgeries being performed are rising every year in Europe. The overall increase in the number of surgeries performed has a substantial impact on the anesthetics market, as they are used in all surgical procedures to reduce the pain during surgery. Along with rising surgeries, factors, such as new anesthetic drugs are also driving the market.

However, general anesthetic drugs cause several side-effects, including nausea, vomiting, dry mouth, sore throat, shivering, muscle aches, disorientation, itching, sleepiness, and mild hoarseness. The other factors, such as lack of skilled anesthetics and regulatory issues are restraining the market growth.

Key Market Trends

Application in Plastic and Cosmetic Surgeries is Expected to Witness High Growth

The advances in plastic surgery have been furthered by the progress in anesthesiology, making it the cornerstone on which the surgical progress has been made. The availability of new anesthetics and adjuvant drugs, advances in trans- and postoperative monitoring, as well as the early prevention of complications have facilitated these advances. The growth of outpatient procedures in cosmetic surgery requires effective anesthetic techniques that allow safe home returns shortly after the surgery is over. It is ideal that no surgical procedure in plastic surgery is performed without the presence of a qualified anesthesiologist.

Moreover, the number of cosmetic procedures has increased in Europe over the years. For instance, as per a 2018 report by International Society of Aesthetic Plastic Surgery, the number of surgical cosmetic procedures in Germany has increased from 308,258 in 2015 to 385,906 in 2018. This has also increased the demand for anesthesia, as it plays a vital role in surgery. Hence, as this trend continues in the future, the market is also expected to grow.

Competitive Landscape

The European anesthesia drugs market is highly competitive and consists of a few major players. In terms of market share, a few of the major players currently dominate the market. Companies like AbbVie Inc., B. Braun Melsungen AG, Baxter, Fresenius SE & Co. KGaA, and Pfizer Inc., among others, hold the substantial market share in the European anesthesia drugs market.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • B. Braun Melsungen
  • Baxter International Inc.
  • F. Hoffmann-La Roche AG
  • Fresenius SE & Co. KGaA
  • Mylan NV
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Number of Surgeries and Emergency Cases
4.2.2 Growing Geriatric Population, coupled with the Rising Prevalence of Chronic Diseases
4.3 Market Restraints
4.3.1 Side Effects of Anesthetic Drugs
4.3.2 Increasing Usage of Generic Anesthesia Drugs and Lack of Skilled Anesthesiologists in the European Countries
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Drug Type
5.1.1 General Anesthesia Drugs
5.1.1.1 Propofol
5.1.1.2 Sevoflurane
5.1.1.3 Desflurane
5.1.1.4 Dexmedetomidine
5.1.1.5 Remifentanil
5.1.1.6 Midazolam
5.1.1.7 Other General Anesthesia Drugs
5.1.2 Local Anesthesia Drugs
5.1.2.1 Bupivacaine
5.1.2.2 Ropivacaine
5.1.2.3 Lidocaine
5.1.2.4 Chloroprocaine
5.1.2.5 Articaine
5.1.2.6 Benzocaine
5.1.2.7 Other Local Anesthesia Drugs
5.2 By Route of Administration
5.2.1 Inhalation
5.2.2 Injection
5.2.3 Other Routes of Administration
5.3 By Application
5.3.1 General Surgeries
5.3.2 Plastic and Cosmetic Surgeries
5.3.3 Dental Surgeries
5.3.4 Other Applications
5.4 Geography
5.4.1 Europe
5.4.1.1 United KIngdom
5.4.1.2 Germany
5.4.1.3 France
5.4.1.4 Italy
5.4.1.5 Spain
5.4.1.6 Rest of Europe

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 AbbVie Inc.
6.1.2 Baxter International Inc.
6.1.3 B. Braun Melsungen
6.1.4 Pfizer Inc.
6.1.5 Fresenius SE & Co. KGaA
6.1.6 Aspen Pharmacare Holdings Limited
6.1.7 F. Hoffmann-La Roche AG
6.1.8 Piramal Group
6.1.9 Mylan NV

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown

Loading
LOADING...

  • AbbVie Inc.
  • Baxter International Inc.
  • B. Braun Melsungen
  • Pfizer Inc.
  • Fresenius SE & Co. KGaA
  • Aspen Pharmacare Holdings Limited
  • F. Hoffmann-La Roche AG
  • Piramal Group
  • Mylan NV
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll